There is 1 paper on major adverse valve events in aging research: 1 trial in people.
1 paper studies it
See all 1 papers on major adverse valve events
- Human trial1
Latest
1 paper in 12 monthsCardiovascular Revascularization Medicine
Tirzepatide therapy reduces subclinical leaflet thrombosis and paravalvular leak after transcatheter aortic valve replacement in obese patients: The TAVR-MET trial
Randomized trial in 260 peopleTirzepatide